Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
Public ClinicalTrials.gov record NCT00406458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Repeat Dosing Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.
Study identification
- NCT ID
- NCT00406458
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 110 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2006 (Type not available)
- Primary completion
- Dec 2008 (Actual)
- Completion
- May 2009 (Actual)
- Last update posted
- Nov 1, 2012
2006 – 2009
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Coordinated Clinical Research | La Jolla | California | 92037 | — |
| Advanced Medical Research, LLC | Lakewood | California | 90712 | — |
| SF Clinical Research Center | San Francisco | California | 94109 | — |
| Diablo Clinical Research | Walnut Creek | California | 94598 | — |
| Bradenton Research Center | Bradenton | Florida | 34205 | — |
| University of Miami, Diabetes Research Institute | Miami | Florida | 33136 | — |
| Neurology Clinical Research | Sunrise | Florida | 33351 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Creighton Diabetes Center | Omaha | Nebraska | 68131 | — |
| Upstate Clinical Research | Albany | New York | 12205 | — |
| Peripheral Neuropathy Center, Weill Medical College of Cornell University | New York | New York | 10022 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Nerve and Muscle Center of Texas | Houston | Texas | 77030 | — |
| DGD Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00406458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2012 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00406458 live on ClinicalTrials.gov.